New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PLT launches Benecarb Glycemic Balance Complex

New ingredient cost-effectively lowers glycemic index of carbohydrate-rich formulations in support of blood sugar management.

PLT Health Solutions Inc. and Horizon Science announced the launch of Benecarb® Glycemic Balance Complex in North America. The ingredient, based on molasses phytonutrients, can reduce the glycemic impact of a broad range of everyday foods and beverages—with particular advantages in carbohydrate-rich formulations.

High in natural antioxidants, minerals and polyphenols, Benecarb has been clinically shown to reduce the glycemic of index (GI) of foods and beverages by up to 20 percent at addition levels of 4 to 6 percent of total carbohydrate content. These low use levels correspond to a low impact on the organoleptic properties of food and beverage formulations and contribute to cost-effectiveness in use. Benecarb is a 100 percent natural, clean-label liquid ingredient that can be added to existing formulations using existing processing equipment, with very little impact on food and beverage labeling. Use of Benecarb can support product claims of lower glycemic index, and consumer claims centered on support for blood sugar management and health.

According to Sid Hulse, director of new product development for PLT Health Solutions, Benecarb Glycemic Balance Complex allows food and beverage companies to develop products that can address the lifestyle and health concerns of a broad range of consumers via blood sugar management. “These days, the blood sugar impact of foods and beverages is on everyone’s mind—from the mom who avoids giving her children beverages that cause a sugar spike and wants foods that help maintain a healthy weight for herself, to the athlete who wants peak performance or the person trying to manage their blood sugar health. The choice of lower glycemic foods and beverages run from emotional and experiential to daily diet management and support of long-term health. Benecarb’s ability to lower the glycemic index of foods responds to all of these drivers,” he said. 

Lowering the glycemic index of foods and beverages
Benecarb Glycemic Balance Complex was developed by Australian-based Horizon Science, where the company maintains a state-of-the-art, production facility for the development of molasses-based ingredients. Benecarb is derived from sugarcane molasses and contains high levels of natural antioxidants, polyphenols and is rich in naturally available minerals. It is the synergistic effect of these micronutrients and plant bioactives that is thought to be the source of Benecarb’s sugar controlling capabilities.

It has received U.S. GRAS certification and UK FSA opinion as being ‘substantially equivalent to molasses’, allowing commercialization in Europe. It is non-GMO, Kosher and Halal compliant. The ingredient is covered by process, application and composition of matter patents.

Used in formulated foods and beverages, Benecarb has been shown to lower the glycemic index of food and beverage systems up to 20 percent based on the 100 point GI scale—and can change the GI classification of a food from high or medium to medium or low. This can support product-based claims of “Low GI” or “Lower GI”. Health benefit-based claims such as “Supports healthy blood sugar,” “Supports blood glucose management,” “Helps improve insulin sensitivity” and “Helps lower blood sugar spikes” are possible.

Clinically studied GI reduction
A series of studies featuring seven everyday carbohydrate-rich foods was conducted to measure Benecarb’s role in reducing glycemic index. Benecarb addition relative to carbohydrate content was correlated to GI reduction. The studies showed that Benecarb reduced GI in all seven applications—by 8 percent to 20 percent. The percentage of GI reduction was shown to be dose-dependent and directly proportional to the amount of Benecarb added as a percentage of available carbohydrate. Equally as important, it was also shown that Benecarb reduced postprandial glucose and insulin response.

According to Dr. Barbara Davis, director of medical and scientific affairs at PLT Health Solutions, these studies can support food and beverage claims that will resonate with consumers who want to make smarter food choices but still want to indulge. “The term glycemic index is beginning to become known by consumers. But people implicitly understand blood sugar management and how it can benefit their lives. A recent consumer survey showed that one-third of consumers would like more ingredients to help balance blood sugar. Blood sugar control is linked to issues such as sustainable energy, weight control and an overall healthier lifestyle. Benecarb can help address all of these issues,” she said.

Sid Hulse discussed the unique potential of Benecarb in the development of appealing new products. “Many ingredient solutions that try to address blood sugar management involve replacing digestible carbohydrates with non-digestible carbohydrates and require substantial reformulation—often with results that impact taste and texture. With other ingredients, the amount of addition required to allow a claim makes them cost prohibitive. With Benecarb, product developers can simply add the ingredient to existing formulations—with little modification—to achieve significant improvements in GI. We think it is a win-win for product developers and consumers. What consumer wouldn’t choose a product that costs the same, offers the same look, taste and experience—but has better blood sugar impact?”


Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.